posted
This small biotech is in phase 3 trials for the treatment of the #1 KILLER IN THE WESTERN WORLD... That's about as big as a drug market can get!
I'm talking about the number of people that die each year from heart attack and stroke. And specifically the buildup of plaque in the arteries that causes it...
Until now, companies have focused on managing risk factors, such as lowering cholesterol or blood pressure. Drugs like Lipitor, for example, lower cholesterol and reduce your risk.
But this small biotech firm we're recommending has a unique product that stops the inflammatory process that contributes to plaque formation. In phase 2 trials it showed it could reduce plaque volume. In other words, IT REMOVES PLAQUE!
This company recently partnered with a major player with expertise in marketing drugs in the competitive cardiovascular market – making it possible to maximize the drug's sales potential...
The terms of the deal are extremely favorable. This company we're recommending could receive $300 million in development milestones and up to another $600 million in sales milestones. Considering its market cap at just $500 million, these are significant amounts of cash.
They'll also receive royalties on the sales of their breakthrough, which could reach several hundred million dollars per year...
And that's a conservative estimate considering an effective drug in this market could easily attain sales of several billion dollars annually.
After all, we're talking about the largest drug market in the world. The potential for a successful drug is enormous...
In fact, Pfizer's Lipitor is the only drug to pass $10 billion in annual sales. Now just imagine what a disruptive innovation could do in this space...
But I have to warn you: this is a time-sensitive opportunity. Top-line data from this study is expected in early 2007. We project if all goes well, this investment could be a 5- to 10-bagger inside of 24 months!
Posts: 81 | From: Mechanicsburg, Pennsylvania | Registered: Feb 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
